Cargando…

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection

HIGHLIGHTS: Major neutralization sites of HPV6 were mapped on the pseudovirus cryo-EM structure; mAb 15F7 binds HPV6 capsid with a novel top-rim binding modality and confers a post-attachment neutralization; mAb 17D5 binds capsid in top-centre manner but unexpectedly prevents virus from attachment t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xinlin, Chen, Jie, Wang, Zhiping, Wang, Daning, He, Maozhou, Qian, Ciying, Song, Shuo, Chi, Xin, Kong, Zhibo, Zheng, Qingbing, Wang, Yingbin, Yu, Hai, Zhao, Qinjian, Zhang, Jun, Li, Shaowei, Gu, Ying, Xia, Ningshao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883418/ https://www.ncbi.nlm.nih.gov/pubmed/31769733 http://dx.doi.org/10.1080/22221751.2019.1694396

Ejemplares similares

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
por: Wang, Daning, et al.
Publicado: (2020)

Viral neutralization by antibody-imposed physical disruption
por: Zheng, Qingbing, et al.
Publicado: (2019)

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus
por: Li, Zhihai, et al.
Publicado: (2017)

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
por: Li, Zhihai, et al.
Publicado: (2018)

Structural Basis for the Shared Neutralization Mechanism of Three Classes of Human Papillomavirus Type 58 Antibodies with Disparate Modes of Binding
por: He, Maozhou, et al.
Publicado: (2021)

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70
por: Qian, Ciying, et al.
Publicado: (2022)

Recent Progress on the Versatility of Virus-Like Particles
por: Qian, Ciying, et al.
Publicado: (2020)

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro
por: Wei, Minxi, et al.
Publicado: (2018)

A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5
por: Xia, Lin, et al.
Publicado: (2016)

Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody
por: Wang, Daning, et al.
Publicado: (2015)

Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
por: Huang, Yang, et al.
Publicado: (2020)

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes
por: Huang, Yang, et al.
Publicado: (2022)

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression
por: Zhou, Lizhi, et al.
Publicado: (2022)

Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions
por: Zhou, Lizhi, et al.
Publicado: (2020)

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice
por: Liu, Liqin, et al.
Publicado: (2022)

Current progress in the development of prophylactic and therapeutic vaccines
por: Li, Tingting, et al.
Publicado: (2022)

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells
por: Wang, Kaihang, et al.
Publicado: (2021)

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates
por: Li, Tingting, et al.
Publicado: (2020)

Structures of pseudorabies virus capsids
por: Wang, Guosong, et al.
Publicado: (2022)

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody
por: Xu, Longfa, et al.
Publicado: (2017)

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs
por: Huang, Weijin, et al.
Publicado: (2020)

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses
por: Li, Tingting, et al.
Publicado: (2022)

T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
por: Zhang, Zhiqing, et al.
Publicado: (2018)

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
por: Li, Tingting, et al.
Publicado: (2021)

Construction of a bacterial surface display system based on outer membrane protein F
por: Chen, Tingting, et al.
Publicado: (2019)

Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal
por: Huang, Xiaofen, et al.
Publicado: (2021)

Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209
por: Ju, Bin, et al.
Publicado: (2022)

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10
por: Zhu, Rui, et al.
Publicado: (2018)

A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode
por: Zhao, Dongping, et al.
Publicado: (2022)

Norovirus Attachment and Entry
por: Graziano, Vincent R., et al.
Publicado: (2019)

Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
por: Zhang, Zhiqing, et al.
Publicado: (2016)

Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation
por: Deng, Tingting, et al.
Publicado: (2022)

Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes
por: Wu, Qian, et al.
Publicado: (2023)

The impact of differences in viral entry and trafficking on the mechanism of HIV-1 neutralization
por: Cincotta, CD Macedo, et al.
Publicado: (2012)

Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation
por: Li, Yike, et al.
Publicado: (2020)

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
por: Xiong, Hualong, et al.
Publicado: (2022)

Master mitotic kinases regulate viral genome delivery during papillomavirus cell entry
por: Rizzato, Matteo, et al.
Publicado: (2023)

P04-40. Dissecting pre- and post-attachment activity of HIV-1 entry inhibitors and neutralizing antibodies
por: Berlinger, L, et al.
Publicado: (2009)

Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2
por: Hu, Jie, et al.
Publicado: (2020)

Investigation of a special neutralizing epitope of HEV E2s
por: You, Min, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qr0jfchc46c10qcicj54v2t9dh